ClinicalTrials.Veeva
Menu

Find clinical trials for Chronic Lymphocytic Leukemia in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Chronic Lymphocytic Leukemia
Leukemia
Lymphoid Leukemia
Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Mantle-Cell Lymphoma

Chronic Lymphocytic Leukemia trials near Houston, TX, USA:

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (453 Ph1 CLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Obinutuzumab
Drug: ABBV-453

Phase 1

AbbVie
AbbVie

Houston, Texas, United States and 20 other locations

To learn if the drug combination pirtobrutinib, venetoclax, and obinutuzumab can help to control relapsed CLL/SLL.

Begins enrollment in 5 months
Small Lymphocytic Leukemia (SLL)
Chronic Lymphocytic Leukemia
Drug: Venetoclax
Drug: Obinutuzumab

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

This phase II trial studies how well acalabrutinib and venetoclax with or without early obinutuzumab work for the treatment of chronic lymphocytic...

Enrolling
Refractory Small Lymphocytic Lymphoma
Recurrent Chronic Lymphocytic Leukemia
Biological: Obinutuzumab
Drug: Venetoclax

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

The goal of this clinical research study is to learn if the combination of lenalidomide and rituximab can help to control CLL. The safety of this dru...

Active, not recruiting
Leukemia
Lymphoma
Drug: Rituximab
Drug: Lenalidomide

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...

Not yet enrolling
Chronic Lymphocytic Leukemia
Non-Hodgkin Lymphoma
Drug: Pirtobrutinib

Phase 4

Lilly
Lilly

Houston, Texas, United States and 34 other locations

monotherapy in participants with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL). This study will also all...

Enrolling
Chronic Lymphocytic Leukemia
Drug: Tocilizumab
Drug: Venetoclax

Phase 1

Roche
Roche

Houston, Texas, United States and 21 other locations

The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing o...

Enrolling
Small Lymphocytic Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Drug: Venetoclax
Drug: Ibrutinib

Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Houston, Texas, United States and 73 other locations

This study is designed to evaluate progression-free survival (PFS) endpoint for acalabrutinib versus (vs) ibrutinib in previously treated chronic...

Active, not recruiting
Chronic Lymphocytic Leukemia
Drug: Ibrutinib
Drug: Acalabrutinib

Phase 3

Acerta Pharma
Acerta Pharma

Houston, Texas, United States and 130 other locations

Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia...

Active, not recruiting
Chronic Lymphocytic Leukemia
Hypogammaglobulinemia
Biological: Panzyga
Other: Placebo

Phase 3

Octapharma

Houston, Texas, United States and 83 other locations

levels of Pirtobrutinib in participants with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib

Phase 2

Loxo Oncology
Loxo Oncology

The Woodlands, Texas, United States and 136 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems